Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herombopag for Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Surgery
NCT06507436Phase 3Completed
- Sponsor
- Hengrui
- Start
- Jul 2024
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hetrombopag in Thrombocytopenia, sponsored by Hengrui. Started Jul 2024; status: completed.
02
Drugs
hetrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT06507436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06507436.